Invasive pulmonary aspergillosis in critically ill patients with COVID-19 in Australia: implications for screening and treatment.
Intern Med J
; 51(12): 2129-2132, 2021 12.
Article
in English
| MEDLINE | ID: covidwho-1583530
ABSTRACT
We report four cases of invasive pulmonary aspergillus co-infection in patients with coronavirus disease 2019 (COVID-19) infection and acute respiratory distress syndrome requiring intensive care unit (ICU) admission. Aspergillus fumigatus and Aspergillus terreus were isolated, with early infection onset following ICU admission. Clinicians should be aware of invasive pulmonary aspergillosis in ICU patients with COVID-19 infection, particularly those receiving dexamethasone. We propose screening of these high-risk patients with twice-weekly fungal culture from tracheal aspirate and, if feasible, Aspergillus polymerase chain reaction. Diagnosis is challenging and antifungal treatment should be considered in critically ill patients who have new or worsening pulmonary changes on chest imaging and mycological evidence of infection.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Invasive Pulmonary Aspergillosis
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Intern Med J
Journal subject:
Internal Medicine
Year:
2021
Document Type:
Article
Affiliation country:
Imj.15602
Similar
MEDLINE
...
LILACS
LIS